The Exopulse Mollii Suit Study - a Database for Routine Follow-up of Clinical Outcomes

Launched by EXONEURAL NETWORK AB · Jun 12, 2023

Keywords

ClinConnect Summary

The Exopulse Mollii Suit Study is looking at how a special suit, called the Exopulse Mollii Suit, can help people with conditions like cerebral palsy, multiple sclerosis, stroke, spinal cord injuries, and other neurological disorders. The main goal of this study is to see if wearing the suit can improve balance and reduce the risk of falls, which will be measured using a balance test called the Berg/Pediatric Balance Scale.

To participate in the study, individuals must be at least 2 years old and have been diagnosed with one of the targeted conditions for more than six months. They also need to be able to understand and follow instructions. Unfortunately, not everyone will be eligible; for example, if someone has certain health issues related to the suit or has recently started new medications that affect muscle activity, they won't be able to join. The study is not yet recruiting participants, but once it starts, those who qualify can expect to wear the suit and take part in assessments that will help researchers understand its effects over time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed with CP, MS, stroke, spinal cord injury or other neurologic disorder that may cause such type of symptoms.
• • Diagnosed \>6 months prior to inclusion in case of MS, stroke, or SCI
• • Give written informed consent
• • Cognitively able to understand and follow verbal and/or written instructions
• • A minimum age of 2 years
• Exclusion Criteria:
• • Any of the contraindications listed in the instructions for use of the Exopulse Mollii Suit
• • Being introduced to any new medication affecting the neuromuscular activity during the study period
• • Using botulinum toxin \<3 month before or during the study period
• • Subjects \<100 cm and \<13 kg
• • Subjects \>205 cm and \>115 kg